NOD/SCID-GAMMA Mice Are an Ideal Strain to Assess the Efficacy of Therapeutic Agents Used in the Treatment of Myeloma Bone Disease

Michelle A. Lawson; Julia M. Paton-Hough; Holly R. Evans; Rebecca E. Walker; William Harris; Dharshi Ratnabalan; John A. Snowden; Andrew D. Chantry

doi:10.1371/journal.pone.0119546

Loading metrics

Open Access

Peer-reviewed

Research Article

NOD/SCID-GAMMA Mice Are an Ideal Strain to Assess the Efficacy of Therapeutic Agents Used in the Treatment of Myeloma Bone Disease

Michelle A. Lawson ,

* E-mail: m.a.lawson@sheffield.ac.uk

¶‡ These authors are joint first authors on this work.

Affiliations Department of Oncology, University of Sheffield, Sheffield, United Kingdom, Mellanby Centre for Bone Research, University of Sheffield, Sheffield, United Kingdom
⨯
Julia M. Paton-Hough ,

¶‡ These authors are joint first authors on this work.

Affiliations Department of Oncology, University of Sheffield, Sheffield, United Kingdom, Mellanby Centre for Bone Research, University of Sheffield, Sheffield, United Kingdom
⨯
Holly R. Evans,

Affiliations Department of Oncology, University of Sheffield, Sheffield, United Kingdom, Mellanby Centre for Bone Research, University of Sheffield, Sheffield, United Kingdom
⨯
Rebecca E. Walker,

Affiliations Department of Oncology, University of Sheffield, Sheffield, United Kingdom, Mellanby Centre for Bone Research, University of Sheffield, Sheffield, United Kingdom
⨯
William Harris,

Affiliations Department of Oncology, University of Sheffield, Sheffield, United Kingdom, Mellanby Centre for Bone Research, University of Sheffield, Sheffield, United Kingdom
⨯
Dharshi Ratnabalan,

Affiliations Department of Oncology, University of Sheffield, Sheffield, United Kingdom, Mellanby Centre for Bone Research, University of Sheffield, Sheffield, United Kingdom
⨯
John A. Snowden,

Affiliations Department of Oncology, University of Sheffield, Sheffield, United Kingdom, Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom
⨯
Andrew D. Chantry

Affiliations Department of Oncology, University of Sheffield, Sheffield, United Kingdom, Mellanby Centre for Bone Research, University of Sheffield, Sheffield, United Kingdom, Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom
⨯

NOD/SCID-GAMMA Mice Are an Ideal Strain to Assess the Efficacy of Therapeutic Agents Used in the Treatment of Myeloma Bone Disease

Michelle A. Lawson,
Julia M. Paton-Hough,
Holly R. Evans,
Rebecca E. Walker,
William Harris,
Dharshi Ratnabalan,
John A. Snowden,
Andrew D. Chantry

Published: March 13, 2015
https://doi.org/10.1371/journal.pone.0119546

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Myeloma cells
Is the Subject Area "Myeloma cells" applicable to this article?

Thanks for your feedback.
Multiple myeloma
Is the Subject Area "Multiple myeloma" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Tibia
Is the Subject Area "Tibia" applicable to this article?

Thanks for your feedback.
Intravenous injections
Is the Subject Area "Intravenous injections" applicable to this article?

Thanks for your feedback.
Histology
Is the Subject Area "Histology" applicable to this article?

Thanks for your feedback.